FC SmithRx Series B, LP — Form D/A
FC SmithRx Series B, LP of NEWTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2022-02-24. $700K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-02-24
- Form: D/A
- Accession: 0001896194-22-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $700K
- Investors: 10
- Date of first sale: 2022-01-31
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-432451
Issuer
- Name: FC SmithRx Series B, LP
- CIK: 0001909083
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 139 GIBBS STREET, NEWTON, MA, 02459
- Phone: 978-273-7692
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Louis Beryl | Executive Officer | SALT LAKE CITY, UT |
| N/A FOUR CITIES FUND V GP, LLC | Executive Officer | NEWTON, MA |
| Matthew McKnight | Executive Officer | NEWTON, MA |
Other filings by this issuer (1)
More